Healthcare Industry - Medical - Pharmaceutical - Biotech in Boston, United States
Non-Opioid Pain Therapeutics Summit
Boston
Tuesday, January 27, 2026
0900
- 1500
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to marke ..
5th mRNA Analytical Development and Quality Control Summit
Boston
Tuesday, February 24, 2026
0800
- 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the mRNA field evolves beyond vaccines into diverse modalities, delivery systems, and therapeutic areas, analytical rigor has never been more critical. With the FDA intensifying scrutiny on CMC packages and new draft guidelines emerging from the EMA, USP, NIST, an ..
7th Inflammasome Therapeutics Summit
Boston
Tuesday, November 4, 2025
0900
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Unlocking the Potential of Targeting the Innate Immune System
After years of rigorous research and foundational progress, the inflammasome drug development field is reaching a critical inflection point. With long-awaited clinical data now beginning to emerge, mome ..
Oligonucleotide-based Therapeutics Summit
Boston
Tuesday, December 9, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Delivering Oligonucleotides with Specificity, Mitigating Off-Target Effects, and Improving Cellular Uptake to Target Undruggable Molecules.
The Oligonucleotide-based Therapeutics Summit is uniting leaders in RNA chemistry, delivery science, and translational biolo ..
7th CNS Drug Delivery Summit
Boston
Tuesday, December 9, 2025
0800
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Despite milestones such as Roche's Trontinemab Brainshuttle™ achieving robust amyloid clearance, challenges remain in reaching targeted brain regions, improving predictive modelling, ensuring efficacy and penetrance, and developing safer, targeted delivery approaches ..
3rd Covalent Drug Discovery and Development Summit
Boston
Tuesday, December 9, 2025
0900
- 1515
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
2025 marks an exciting phase for covalent drugs, with the field doubling down on de-risked assets and tackling high-value targets in oncology, immunology, and beyond. With MOMA Therapeutics recently dosing their first patient with a covalent Werner helicase inhibitor ..
9th DDR Inhibitors Summit
Boston
Tuesday, January 27, 2026
0830
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel ..
2nd Annual Personalized Cancer Vaccine Summit
Boston
Tuesday, November 18, 2025
0830
- 1740
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With industry eagerly anticipating readouts from Merck and Moderna’s Phase 3 trial of adjuvant V940 in combination with Keytruda, BioNTech, and Genentech’s global trials for BNT116 for non-small cell lung cancer, we are advancing ever closer to a commercially approve ..
2nd Proteomic Based Drug Discovery Summit 2026
Boston
Tuesday, February 3, 2026
0800
- 1615
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone, the increasing recognition of proteomics as a transformative force ..
2nd ADC Pharmacokinetics and Clinical Pharmacology Summit | December 9-11, 2025 | Boston, MA
Boston
Tuesday, December 9, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As ADC approvals grow and pipelines expand, dose selection has become one of the field’s biggest challenges, and Project Optimus has resulted in pushing developers to move beyond maximum tolerated dose and define regimens that truly balance safety and efficacy.
In ..
9th Dermatology Drug Development Summit
Boston
Tuesday, November 18, 2025
0900
- 1605
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Industry’s Destination to Discover and Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease.
As the field surges with clinical and commercial momentum, from Sanofi’s continued success with Dupixent, Corvus' promising Phase 1 data on Soquelitinib, a ..
9th Complement-Based Drug Development Summit
Boston
Monday, December 1, 2025
0800
- 1640
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
So far, 2025 has brought significant excitement and progress to the complement-based therapeutic landscape. Leading biopharma companies like Novartis, Annexon Biosciences and Omeros, are making significant clinical progress in PNH, AMD, IgAN and C3G, whilst key acade ..
7th Cell Therapy Analytical Development Summit
Boston
Monday, December 1, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With robust, reliable and regulatory-ready analytics lying at the heart of clinically successful cell therapies, now is the time to elevate your current workflows and strategies to prepare for clinical and commercial readiness.
Remaining the industry’s leading for ..
LEAP HR: Emerging Biopharma 2025
Boston
Tuesday, November 4, 2025
0730
- 1700
1849.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With continued financial uncertainty and waves of layoffs reshaping the pre-commercial biopharma landscape, it's never been more critical for HR leaders in this space to come together, share what's working, and reimagine how people strategy can keep pace with fast-ch ..
2nd Patient Recruitment in Rare Disease Trials
Boston
Tuesday, November 4, 2025
0900
- 1700
2999.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The rare disease trial landscape stands at a pivotal tipping point. While unprecedented advances in trial design, digital tools, and regulatory flexibility are accelerating innovation like never before, the reality for patients remains stark: over 90% of rare disease ..
Model-Informed Drug Development Summit
Boston
Tuesday, November 18, 2025
0800
- 1545
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Model-Informed Drug Development Summit is the first and only industry-focused, 3-day strategic meeting on how MIDD is reshaping decision-making and accelerating success in drug development. With the release of the draft ICH M15 guidelines and the FDA’s move to ph ..
Designing the AI-Enabled Biopharma Workforce 2025
Boston
Tuesday, December 2, 2025
0800
- 1730
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As AI reshapes the biopharma landscape, nearly every role within our organizations is poised for transformation - but the path forward remains uncertain. What is clear, however, is that the future hinges on the choices we make today.
The most innovative companies, ..
8th RNA-Targeted Drug Discovery and Development Summit
Boston
Tuesday, December 2, 2025
0700
- 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
RNA-targeting small molecules are rapidly emerging as a powerful therapeutic reality. From modulating splicing to directly binding RNAs, these molecules offer a revolutionary approach to treating previously undruggable diseases across neurodegenerative, cancer and ra ..
9th Antifibrotic Drug Development Summit
Boston
Monday, November 17, 2025
0830
- 1530
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The antifibrotic field is at an inflection point: Madrigal’s Resmetirom secured the first-ever MASH approval in 2024, Boehringer’s nerandomilast hit its Phase 3 endpoint in IPF, and pharma giants like Lilly and GSK are investing billions in fibrosis pipelines. Yet, w ..
7th RNAi-Based Therapeutics Summit
Boston
Tuesday, January 27, 2026
0800
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond
The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum f ..
14th Alzheimer's and Parkinson's Drug Development Summit
Boston
Tuesday, February 3, 2026
0800
- 1700
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanema ..
3rd LNP Characterization and Analytical Development Summit
Boston
Tuesday, November 18, 2025
0730
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
LNPs continue to dominate as the non-viral delivery vehicle of choice given their ability to encapsulate fragile payloads, such as mRNA, siRNA, gRNA and more, and deliver them into target cells with high efficacy. However, critical challenges remain in assessing targ ..
4th Molecular Glue Drug Development Summit | Boston, MA | January 27-29, 2026
Boston
Tuesday, January 27, 2026
0830
- 1545
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Enabling Rapid Target Selection, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent, Selective and Safer Cures for Cancer and Beyond.
Molecular glues are leading the charge in the race to drug the previously undruggable, ..
7th Gene Therapy for CNS Summit
Boston
Tuesday, October 28, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 7th Gene Therapy for CNS Summit returns to Boston this October and is the only industry-led conference dedicated to innovating and optimizing gene therapies for CNS disorders. With the changing regulatory landscape, the push to advance through the clinic and be f ..
13th IMPACCT Real-World Evidence Summit 2025
Boston
Monday, October 27, 2025
0900
- 1645
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the CMS introduces new guidance for RWD studies, the FDA announces a RWE Center to promote its use in regulatory decision-making, and RWD becomes more accessible, investment is pouring into RWE generation. It is evident RWE will play an increasingly pivotal role i ..
8th Annual TPD and Induced Proximity Summit
Boston
Monday, October 27, 2025
0730
- 1700
2899.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the TPD field eagerly awaits the approval of Arvinas's Vepdegestrant, and with C4 Therapeutics and Kymera progressing through Phase 1 and 2 clinical trials, 2025 is poised to be the year of clinical validation for TPD. This has been echoed in the flurry of partner ..
3rd ADC Process Development Summit
Boston
Wednesday, October 22, 2025
0900
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Underpinning successful ADC development is a robust, reproducible, and scalable process development strategy. From controlling impurities and optimizing conjugation yield to streamlining unit operations and executing technology transfer, it’s clear that the path to s ..
3rd Spatial Biology for Drug Development Summit 2025
Boston
Wednesday, October 22, 2025
0700
- 1700
0.50 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As spatial biology technology advances, delivering unprecedented resolution, multiplexing, and reproducibility, new insights into disease biology are driving major breakthroughs across multiple therapeutic areas. Yet, key barriers still limit the full application of ..
7th Gene Therapy Analytical Development Summit 2025
Boston
Tuesday, October 21, 2025
0800
- 1715
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As gene therapies evolve beyond AAV to include mRNA, CRISPR-based platforms, and novel capsids, analytical strategies must advance in parallel to meet rising complexity and regulatory expectations. With increased pressure for analytical rigor, potency relevance, and ..
10th Computational Drug Development For Biologics Summit 2025
Boston
Tuesday, October 14, 2025
0830
- 1700
2099.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The landscape of biologics discovery is rapidly evolving, driven by breakthroughs in AI, an influx of high-quality datasets, and regulatory momentum supporting in silico approaches. As industry leaders look to streamline R and D and de-risk development, there is a cr ..
T-Cell Engager for Autoimmune Disease Summit
Boston
Tuesday, October 14, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The T-Cell Engager for Autoimmune Disease Summit is the first and only industry-dedicated meeting designed to unlock the full potential of TCEs beyond oncology into autoimmune diseases like lupus, rheumatoid arthritis, and multiple sclerosis. As the field accelerates ..
Joslin Diabetes Center International Symposium - Oct 7-9, 2025 in Boston, MA
Boston
Tuesday, October 7, 2025
1400
- 1145
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
2025 Joslin International Symposium
This year's symposium's theme is "Inter-Organ Communication in the Pathogenesis and Treatment of Diabetes and Obesity." It will bring together world-renowned investigators to explore the complex metabolic interactions among key or ..
2nd Raw Materials for Cell and Gene Therapy Summit | October 7-9, Boston, MA
Boston
Tuesday, October 7, 2025
0900
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Securing High Grade Raw Materials for a Smoother Supply Chain...
Unlock the future of cell and gene therapy manufacturing at the 2nd Raw Materials for Cell and Gene Therapy Summit. This is your exclusive opportunity to hear directly from regulatory and standards l ..
3rd Fluid and Imaging Biomarkers in Neuroscience Summit
Boston
Tuesday, October 7, 2025
0800
- 1700
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the only industry-driven forum focused exclusively on biomarker discovery and validation for neurodegenerative and neuroinflammatory diseases, the 3rd Fluid and Imaging Biomarkers in Neuroscience Summit unites biotech, pharma and academic scientists to transform d ..
Immune Cell Engager Partnering and Investment Summit
Boston
Tuesday, September 30, 2025
0800
- 1600
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Immune Cell Engager Partnering and Investment Summit is here. As part of the game-changing Partnering and Investment Series, it's the first-ever partnering forum for next-gen engager deal-making. It brings together top biotech companies leading engager and multis ..
6th Genome Editing Therapeutics Summit
Boston
Monday, September 29, 2025
0830
- 1715
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 6th Genome Editing Therapeutics Summit
2025 has been industry-defining for the genome editing space. With baby KJ successfully receiving the world's first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, a ..
9th MASH Drug Development Summit 2025
Cambridge
Monday, September 29, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Driven by a surging pipeline, the MASH therapeutic landscape is radically transforming as more drugs reach clinical trials. While Madrigal's Rezdiffra marked a groundbreaking first approval, it also highlighted the vast scope for further, more comprehensive, patient- ..
15th Injectable Device Development Summit
Boston
Wednesday, September 24, 2025
0800
- 1700
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
The drug delivery landscape is evolving rapidly, with micro moulding driving evolving trends in self-injection devices and increasing drive towards sustainability. At the same time, sweeping regulatory shifts are reshaping the future of combination product developmen ..
7th Exosome-Based Therapeutic Development Summit
Boston
Tuesday, September 23, 2025
0830
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The exosome and extracellular vesicles (EV) fields are on the verge of groundbreaking clinical and commercial breakthroughs with therapeutic progress hailed from key biopharma including Rion, Direct Biologics, Aegle Therapeutics, Aruna Bio, EXO Biologics, and more!
..
10th CAR-TCR Summit
Boston
Tuesday, September 23, 2025
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Hope is renewed for the cell therapy industry in 2025 fuelled by a 30% year on year increase in investment, notably in the cases of Arsenal Bio, Enara Bio and AvenCell. Landmark approvals for solid tumors from Adaptimmune and Iovance, along with significant clinical ..
LEAN Cell and Gene Boston Summit
Boston
Monday, September 22, 2025
1200
- 1840
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
Despite tremendous scientific progress, stunning clinical results, and a slew of commercial approvals, this paradigm shifting industry finds itself facing an increasingly oppressive macro-economic climate.
Public and private investment in CGT is trending downwards ..
15th World Clinical Biomarkers and CDx Summit | September 22-25, 2025 | Boston, MA
Boston
Monday, September 22, 2025
0800
- 1800
0.50 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Driven by advancements in genomic profiling, omics, and AI technologies, the biomarkers and diagnostics field continues to surge, with Roche and AstraZeneca’s world-first digital pathology CDx approval in April taking the number of approved CDx tests to a record high ..
Autoimmunity and Inflammation Partnering and Investment Summit 2025
Boston
Monday, September 22, 2025
0800
- 1500
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Returning for its second year, the Autoimmunity and Inflammation Partnering and Investment Summit unites over 80 on-scope and in-strategy companies to increase your success rate, efficiency, and collaborative outcomes.
Unite to:
Capitalize on protected face-to- ..
3rd CRISPR-Based Therapy Analytical Development 2025
Boston
Tuesday, September 16, 2025
0900
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 3rd CRISPR-Based Therapy Analytical Development Summit
Spearheading Regulatory Compliance of Genome Editing Therapies
The 3rd CRISPR-Based Therapy Analytical Development Summit returns to Boston this September as the only industry-led meeting dedic ..
Cancer R&D World Conference 2025 (CRDWC 2025)
Boston
Wednesday, September 10, 2025
0900
- 1700
599.00 GBP
Healthcare Industry - Medical - Pharmaceutical - Biotech
Precision Global Conference cordially invites you to our Cancer R&D World Conference (CRDWC 2025) HYBRID EVENT, Which Will Be Held from 10 to 12 September 2025 in Boston, Massachusetts, USA.
Conference theme: “Innovating Cancer Care: Pioneering Research and Develop ..
8th Neuropsychiatric Drug Development Summit
Boston
Tuesday, September 9, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
2025 continues to deliver progress, fueled by innovations in new mechanisms of action to improve neurotransmission, promote neuroplasticity, alleviate side effects, and more. However, as unmet needs rise and inherent challenges of heterogeneity, translatability, and ..
2nd Annual ADC and Novel Conjugates Partnering and Investment Summit
Boston
Tuesday, September 9, 2025
0750
- 1600
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Back for its second year, the ADC Partnering and Investment Summit unites 100+ top ADC companies, pharma leaders, and investors for hyper-aligned and more efficient business networking.
Unite with other ADC business development leaders where cutting-edge science m ..
6th In-House Impact: Biopharma Summit 2025
Boston
Wednesday, August 27, 2025
0900
- 1700
0.50 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit is your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more ..
5th Oligonucleotides for CNS Summit
Boston
Wednesday, August 27, 2025
0830
- 1605
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With clinical momentum from Eli Lilly's lipidated brain shuttle siRNAs, Alnylam Pharmaceuticals' ALN-APP siRNA, Wave's Phase 1b/2a positive SELECT-HD data, 170+ biotech and 30+ pharma active in the field, and a surge of novel approaches, the oligonucleotide field sho ..
4th Oligonucleotides Analytical Development and CMC
Boston
Monday, August 25, 2025
0800
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Uniting Biotech and Pharma Experts to Exchange Insights on Oligonucleotide Analytical Development and CMC.
Despite milestone progress, such as Avidity securing breakthrough designation for their oligo conjugate, significant challenges persist across the oligo land ..